• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
134 results

Jeisys Medical Inc. v. Serendia, LLC

Docket IPR2024-00384, Patent Trial and Appeal Board (Jan. 8, 2024)
Carl DeFranco, Michael Woods, Scott Raevsky, Sheridan Snedden, Tina Hulse, presiding
Case TypeInter Partes Review
Patent
9320536
DeadlineDUE DATE 5: April 16, 2025 Petitioner’s sur-reply to the opposition to the motion to amend Motion to exclude evidence
DeadlineDUE DATE 6: April 23, 2025 Opposition to motion to exclude Request for pre-hearing conference
Patent Owner Serendia, LLC
Petitioner Jeisys Medical Inc.
Petitioner Endymed Medical
...
cite Cite Docket
Analyze

38 Order on Motion: Order on Motion

Document IPR2024-00384, No. 38 Order on Motion - Order on Motion (P.T.A.B. Mar. 13, 2025)
ENDYMED MEDICAL LTD. and
1 This is a consolidated Order for all three proceedings.
The parties shall not use this heading in any subsequent papers.
Following joinder of petitioners EndyMed Medical Ltd. and EndyMed Medical, Inc. (collectively, “EndyMed”) in the above-identified proceedings, we extended the due date for the final written decision in each proceeding from July 22, 2025, to December 22, 2025.
2 We refer only to the paper in IPR2024-00383.
cite Cite Document
Analyze

37 Order on Motion: Adjusting One Year Pendency Due to Joinder 35 USC § 316a11 37 CFR § 42100c

Document IPR2024-00384, No. 37 Order on Motion - Adjusting One Year Pendency Due to Joinder 35 USC § 316a11 37 CFR § 42100c (P.T.A.B. Mar. 13, 2025)
On July 22, 2024, we instituted an inter partes review in each of the above-identified proceedings based on a petition filed by Jeisys Medical Inc. (“Jeisys”).
On January 31, 2025, EndyMed and patent owner, Serendia, LLC, jointly proposed that several due dates be extended by about three months for the purpose of accommodating discovery.
Normally, a final decision in an inter partes review is due “not later than 1 year after the date on which the Director notices the institution of a review ... except that the Director ... may adjust the time periods in this paragraph in the case of joinder under section 315(c).” 35 U.S.C. § 316(a)(11)(emphasis added).
In the case of joinder, the Director has delegated the authority to adjust the one- year period to the Board.
That being the case, we adjust the pendency time of these proceedings before the Board so as to adequately consider and decide all the pending issues.
cite Cite Document
Analyze

36 Order Other: Order Granting Termination Due to Settlement Only as to Petitione...

Document IPR2024-00384, No. 36 Order Other - Order Granting Termination Due to Settlement Only as to Petitioner Jeisys Medical Inc 35 USC 317 37 CFR 4274 (P.T.A.B. Feb. 4, 2025)

cite Cite Document
Analyze

35 Notice Other: Institution decision and grant of joinder, IPR2024 00844

Document IPR2024-00384, No. 35 Notice Other - Institution decision and grant of joinder, IPR2024 00844 (P.T.A.B. Jan. 10, 2025)

cite Cite Document
Analyze

26 Order on Motion: ORDER Granting Patent Owner’s Motion for Admission Pro Ha...

Document IPR2024-00384, No. 26 Order on Motion - ORDER Granting Patent Owner’s Motion for Admission Pro Hac Vice of Cecilia Peniza 37 CFR § 4210c (P.T.A.B. Nov. 12, 2024)

cite Cite Document
Analyze

20 Order on Motion: ORDER Granting Patent Owner’s Motion for Protective Order ...

Document IPR2024-00384, No. 20 Order on Motion - ORDER Granting Patent Owner’s Motion for Protective Order Granting Patent Owner’s Motion to Seal 37 CFR §§ 425, 4254 (P.T.A.B. Jul. 26, 2024)

cite Cite Document
Analyze

18 Institution Decision Grant: Institution Decision Grant

Document IPR2024-00384, No. 18 Institution Decision Grant - Institution Decision Grant (P.T.A.B. Jul. 23, 2024)

cite Cite Document
Analyze
1 2 3 4 5 ... 8 9 10 >>